Optimist Retirement Group’s Gilead Sciences GILD Stock Holding History

Optimist Retirement Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Sell	20,271 -841	-4%	-$118K	1.25%	14
2025 Q4	$2.59M	Buy	21,112 +1	+0%	+$122	1.19%	23
2025 Q3	$2.34M	Sell	21,111 -1,758	-8%	-$200K	1.06%	29
2025 Q2	$2.54M	Sell	22,869 -435	-2%	-$46.3K	1.22%	17
2025 Q1	$2.61M	Sell	23,304 -2,777	-11%	-$287K	1.31%	12
2024 Q4	$2.41M	Sell	26,081 -1,153	-4%	-$104K	1.14%	18
2024 Q3	$2.28M	Buy	27,234 +1,391	+5%	+$106K	1.03%	29
2024 Q2	$1.77M	Buy	25,843 +2,009	+8%	+$134K	0.93%	37
2024 Q1	$1.75M	Buy	23,834 +2,979	+14%	+$229K	0.9%	36
2023 Q4	$1.69M	Buy	+20,855	New	+$1.62M	1.1%	23

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Optimist Retirement Group's GILD Position: Q1 2026 in Review

Optimist Retirement Group reduced its Gilead Sciences (GILD) stake by 4% in Q1 2026, selling an estimated $118K and leaving 20,271 shares worth $2.83M. The position accounts for 1.25% of the portfolio, ranked #14.

Optimist Retirement Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Optimist Retirement Group held 20,271 shares of Gilead Sciences worth $2.83M as of Q1 2026.
Optimist Retirement Group sold 841 Gilead Sciences shares in Q1 2026, an estimated $118K.
Gilead Sciences made up 1.25% of Optimist Retirement Group's portfolio in Q1 2026, its #14 holding.
Optimist Retirement Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Optimist Retirement Group's 13F filing for Q1 2026, filed 11 May 2026.